Related Experiment Videos
Comparative activity of ciprofloxacin against anaerobic bacteria
Antimicrobial Agents and Chemotherapy
|March 1, 1985
Abstract:
The in vitro activity of ciprofloxacin was assessed against 362 strains of anaerobic bacteria and compared with that of cefoxitin, clindamycin, metronidazole, and mezlocillin. Only 31% of the strains tested were susceptible to ciprofloxacin. The other agents were active against most of the strains tested.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Local review of treatment of hand enchondroma (artificial bone substitute versus autologous bone graft) in a tertiary referral centre: 13 years' experience.
Hong Kong medical journal = Xianggang yi xue za zhi·2015
Exocellular phospholipase C activity from a Propionibacterium acnes strain isolated from a periodontal pocket.
Journal of periodontology·1997
Comparative activity of SCH 34343 against anaerobic bacteria.
Diagnostic microbiology and infectious disease·1986
Establishment of MICs of moxalactam for control and reference anaerobic organisms in agar dilution and microdilution techniques.
Antimicrobial agents and chemotherapy·1985
Anaerobes as normal oral flora.
Reviews of infectious diseases·1984
In vitro and in vivo activity of OSUAB-0284, a preclinical candidate for Staphylococcus aureus infections.
Antimicrobial agents and chemotherapy·2026
Activity of oral β-lactams, tebipenem and ceftibuten, combined with novel oral β-lactamase inhibitors against broad-spectrum β-lactamase-producing Escherichia coli.
Antimicrobial agents and chemotherapy·2026
A multivalent CPS-CRM197 conjugate vaccine protects against severe/fatal Klebsiella pneumoniae disease in a mouse infection model.
Antimicrobial agents and chemotherapy·2026
Rifampicin-resistant Staphylococcus epidermidis implant-associated infections: the therapeutic potential of ceftaroline and daptomycin combinations.
Antimicrobial agents and chemotherapy·2026
Expanding threat of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in Peru: genomic and phenotypic evidence of high-risk clones dissemination.
Antimicrobial agents and chemotherapy·2026
Dual-stage inhibition of Plasmodium falciparum by a Skeletocutis-derived fungal metabolite targeting pyruvate kinase II.
Antimicrobial agents and chemotherapy·2026
Two C6 transcription factors act as host immune terminator (HitA) and regulator of insect pathogenicity (Rip4) in Beuaveria bassiana.
Pesticide biochemistry and physiology·2026
Multi-omics-driven predictive modelling of antimicrobial resistance emergence in African food value chains under climate change scenarios.
Food research international (Ottawa, Ont.)·2026
Exploring the antibiofilm potential of marine Streptomyces sp. VITNABS17 against biofilm forming Klebsiella pneumoniae: an in vitro and in silico approach.
Preparative biochemistry & biotechnology·2026
Type VI secretion drives reciprocal growth inhibition among symbiotic Vibrio fischeri strains.
Microbiology (Reading, England)·2026